Neonatal respiratory health
Research activity includes prevention of lower respiratory tract infections and wheezing in moderate-late preterm infants, with attention to early-life respiratory vulnerability and immune development.
- Preterm-born infants
- Bacterial lysates
- Respiratory infection prevention
The clinical focus is on reducing early recurrent respiratory illness in infants at increased risk of later airway symptoms.
Severe asthma
Trials address severe eosinophilic asthma and severe T2-high asthma, with interest in maintaining asthma control while adapting biologic treatment schedules.
- Mepolizumab
- Dupilumab
- Biomarker-guided asthma care
Research activity is centered on long-term management of difficult-to-control asthma and the use of inflammatory markers such as eosinophils and FeNO.
Obesity and metabolic disease
The sponsor supports studies in morbid obesity and obesity with related cardiometabolic risk factors, including people with type 2 diabetes, dyslipidaemia, or controlled hypertension.
- BMI-based obesity care
- Cardiometabolic comorbidity
- Weight-related liver disease
Areas of interest also include moderate to severe liver fibrosis in the setting of excess body weight and metabolic risk.
Gastrointestinal surgery and perioperative care
Clinical research extends to patients undergoing gastric bypass surgery, with attention to surgical bleeding risk and perioperative haemostasis in the context of morbid obesity.
- Tranexamic acid
- Haemorrhage reduction
- Bariatric surgery
This area reflects interest in improving safety outcomes for patients receiving bariatric procedures.
